GLP-1 & Weight Management

Research peptides for metabolic and weight management studies including GLP-1 receptor agonists, dual and triple agonists, and metabolic modulators.

View as Grid List

Sort by

Display per page

Semaglutide Capsules (500mcg) 25 Count

Oral semaglutide is a 31-amino acid GLP-1 receptor agonist with engineered modifications (Aib8, C-18 fatty di-acid, Lys34Arg) enabling oral bioavailability via SNAC absorption enhancement technology. Research demonstrates glycemic control comparable to injectable GLP-1 agonists with 15.1% weight loss (50mg dose, OASIS-1 trial).

$99.00

AOD-9604 5mg

Synthetic hGH Fragment: 16-amino acid C-terminal peptide (177-191), ≥98% purity
Beta-3-AR Upregulation: Enhances lipolysis while suppressing lipogenesis without IGF-1 elevation
Metabolic Research: Six human trials (900+ participants), FDA GRAS status

$53.00

5-Amino-1MQ 50mg (60 Capsules)

NNMT Inhibitor: Small-molecule inhibitor of nicotinamide N-methyltransferase (IC50 = 1.2 μM), ≥98% purity
NAD+ Salvage Enhancement: Preserves nicotinamide for NAD+ biosynthesis; elevates intracellular NAD+ by 1.2-1.6-fold
Metabolic Research: Studied in obesity, muscle aging, cardiovascular function, and neurodegenerative disease models

$99.00